Search results for "far"

showing 10 items of 6421 documents

Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary …

2001

Abstract OBJECTIVES We sought to determine the effectiveness of primary angioplasty compared with thrombolysis in clinical practice. BACKGROUND In clinical practice, primary angioplasty for the treatment of acute myocardial infarction (AMI) has not yet been proven more effective than intravenous thrombolysis, nor have subgroups of patients been identified who would perhaps benefit from primary angioplasty. METHODS The pooled data of two AMI registries—the Maximal Individual TheRapy in Acute myocardial infarction (MITRA) study and the Myocardial Infarction Registry (MIR)—were analyzed. A total of 9,906 lytic-eligible patients with AMI, with a pre-hospital delay of ≤12 h, were treated with ei…

medicine.medical_specialtyUnivariate analysisbusiness.industrymedicine.medical_treatmentAbsolute risk reductionThrombolysisOdds ratiomedicine.diseaseConfidence intervalInternal medicineConcomitantAngioplastyCardiologyMedicineMyocardial infarctionbusinessCardiology and Cardiovascular MedicineJournal of the American College of Cardiology
researchProduct

249 Validation of assessment of circulate oxidative stress markers by the Free Oxygen Radicals Testing (FORT) assay among patients with an acute myoc…

2011

BackgroundFree oxygen radicals play an important role in the pathogenesis of many diseases including cardiovascular diseases, diabetes, cancer and aging. Several methods were developed for the direct or indirect measurement of oxygen free radical and its by-products. Using a new Free Oxygen Radicals Testing (FORT) the current study is designed first to validate the device and to investigate the potential relationships between the ROS and clinical or biological factors in human serum from a population of men with an acute myocardial infarction (AMI).MethodsWe first determined the effect of storage, variability and reproducibility of the FORT test in serum. Then we used the test in 66 patient…

medicine.medical_specialtyUnivariate analysiseducation.field_of_studyEjection fractionbusiness.industryPopulationCancermedicine.disease_causemedicine.diseaseSurgeryPathogenesisDiabetes mellitusInternal medicinemedicineCardiologyMyocardial infarctionCardiology and Cardiovascular MedicinebusinesseducationOxidative stressArchives of Cardiovascular Diseases Supplements
researchProduct

A Review of Occlusion as a Tool to Assess Attentional Demand in Driving

2021

Objective The aim of this review is to identify how visual occlusion contributes to our understanding of attentional demand and spare visual capacity in driving and the strengths and limitations of the method. Background The occlusion technique was developed by John W. Senders to evaluate the attentional demand of driving. Despite its utility, it has been used infrequently in driver attention/inattention research. Method Visual occlusion studies in driving published between 1967 and 2020 were reviewed. The focus was on original studies in which the forward visual field was intermittently occluded while the participant was driving. Results Occlusion studies have shown that attentional demand…

medicine.medical_specialtyVehicle EngineeringComputer sciencesystem-pacedHuman Factors and Ergonomicsvisual demandnäkökenttäself-pacedFarkostteknikautoilijatBehavioral NeurosciencePhysical medicine and rehabilitationhavainnointiSpare partOcclusionPeripheral visionmedicineperipheral visionminimum required attentiontarkkaavaisuusVisual occlusionApplied PsychologySelf paced
researchProduct

Diagnosis and Treatment of Lower Extremity Venous Thromboembolism

2020

Importance: Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to 112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from 20% to 36% during the 10 years after an initial event.Observations: PubMed and Cochrane databases were searched for English-language studies published from January 2015 through June 2020 for randomized clinical trials, meta-analyses, systematic reviews, and observational studies. Risk factors for venous thromboembolism (VTE), such as older age, malignancy (cumulative incidence of 7.4% after a median of 19 months), inflammatory disorders (VTE risk is 4.7% in patients with rheumatoid arthritis and 2.5% in those withou…

medicine.medical_specialtyVena Cava FiltersDeep vein01 natural sciencesPostthrombotic Syndromelaw.inventionFibrin Fibrinogen Degradation Products03 medical and health sciencesSex Factors0302 clinical medicineRandomized controlled trialPredictive Value of TestsRisk FactorslawInternal medicineMedical IllustrationFactor V LeidenHumansThrombophiliaMedicineCumulative incidencecardiovascular diseases030212 general & internal medicine0101 mathematicsLife StyleThrombectomyUltrasonographybusiness.industry010102 general mathematicsAge FactorsWarfarinVenous ThromboembolismGeneral Medicinemedicine.diseaseThrombosisPre- and post-test probabilitymedicine.anatomical_structureLower ExtremityPredictive value of testsWarfarinSymptom AssessmentbusinessBiomarkersFactor Xa Inhibitorsmedicine.drugJAMA
researchProduct

New frontiers in anticoagulation: non vitamin-K oral anticoagulants in stroke prevention

2016

ABSTRACTIntroduction: Non vitamin-K oral anticoagulants (NOACs) are direct and specific inhibitors of the coagulation factors IIa (dabigatran) and Xa (apixaban, rivaroxaban, edoxaban) which share many pharmacokinetic properties. However, indications are lacking regarding the use of NOACs during thrombolysis, surgery and bleeding events.Areas covered: In this paper, the authors retrospectively analyzed the relevant literature on the NOACs using the PubMed and Google Scholar databases.Expert commentary: Although warfarin is effective in cardioembolic stroke prevention, easier handling and more favorable risk-benefit profile often render NOACs a more preferable therapy choice for neurologists.…

medicine.medical_specialtyVitamin KPyridonesaspirinmedicine.medical_treatmentAdministration Oral030204 cardiovascular system & hematologyDabigatranAnticoagulation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEdoxabanmedicineHumansatrial fibrillationPharmacology (medical)030212 general & internal medicineIntensive care medicineRivaroxabanAspirinbusiness.industryGeneral Neurosciencenon vitamin-K oral anticoagulantWarfarinAnticoagulantsreverse therapyAtrial fibrillationThrombolysismedicine.diseasemeasure of monitoringStrokewarfarinchemistryAnesthesiaPyrazolesApixabanstroke preventionNeurology (clinical)businessmedicine.drugExpert Review of Neurotherapeutics
researchProduct

Atrial fibrillation and chronic kidney disease: focus on rivaroxaban

2015

Renal insufficiency increases the risk of stroke and bleeding in atrial fibrillation patients. Although vitamin K antagonists reduce the risk of stroke in patients with moderate renal dysfunction, this observation is less clear in patients with renal impairment. Moreover, the risk of bleeding with vitamin K antagonists increases as renal function worsens. Maintaining international normalized ratio values within therapeutic targets is more difficult in patients with renal dysfunction, and those agents may cause warfarin-related nephropathy and vascular calcification. Rivaroxaban is the only nonvitamin K oral anticoagulant with a dose specifically tested in patients with moderate renal insuff…

medicine.medical_specialtyVitamin Kmedicine.drug_classRenal functionurologic and male genital diseasesNephropathyRivaroxabanInternal medicineAtrial FibrillationmedicineHumansRenal Insufficiency ChronicStrokeAgedRivaroxabanbusiness.industryHealth PolicyWarfarinAnticoagulantsAtrial fibrillationVitamin K antagonistmedicine.diseaseStrokeCardiologyWarfarinbusinessFactor Xa Inhibitorsmedicine.drugKidney diseaseJournal of Comparative Effectiveness Research
researchProduct

Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis.

2019

ObjectiveGrip strength is a well-characterised measure of weakness and of poor muscle performance, but there is a lack of consensus on its prognostic implications in terms of cardiac adverse events in patients with cardiac disorders.MethodsArticles were searched in PubMed, Cochrane Library, BioMed Central and EMBASE. The main inclusion criteria were patients with cardiac disorders (ischaemic heart disease, heart failure (HF), cardiomyopathies, valvulopathies, arrhythmias); evaluation of grip strength by handheld dynamometer; and relation between grip strength and outcomes. The endpoints of the study were cardiac death, all-cause mortality, hospital admission for HF, cerebrovascular accident…

medicine.medical_specialtyWeaknessMultivariate analysisHeart diseaseHeart Diseasesheart failure030204 cardiovascular system & hematologyCochrane LibraryHeart diseaseGlobal HealthNO03 medical and health sciencesGrip strength0302 clinical medicinePatient AdmissionInternal medicineCause of DeathHeart disease; heart failure; meta-analysis; Cardiology and Cardiovascular MedicinemedicineHumans030212 general & internal medicineMyocardial infarctionHand Strengthbusiness.industrymedicine.diseasePrognosishumanitiesSurvival Ratemeta-analysisCardiovascular System & HematologyMeta-analysisHeart failureCardiologymedicine.symptombusinessCardiology and Cardiovascular Medicine
researchProduct

Air pollution and stroke. A new modifiable risk factor is in the air

2019

Abstract Evidence from epidemiological studies has demonstrated that outdoor air pollution is now a well-known major problem of public health, mainly in low and middle income countries. Contrasting with myocardial infarction , there are few data on the association of air pollution and stroke. Methods We propose a narrative literature review of the effects and the underlying biological mechanisms of short- and long-term exposure to air pollutants on stroke risk and mortality, using the following key-words: stroke, cerebrovascular events, ischemic and haemorrhage stroke, transient ischaemic attack , mortality, air pollution and air pollutants. Results Twenty-one papers were selected. Air poll…

medicine.medical_specialty[SDV]Life Sciences [q-bio]Air pollutionComorbiditymedicine.disease_causeEffect Modifier Epidemiologic03 medical and health sciences0302 clinical medicineRisk FactorsEnvironmental healthAir PollutionEpidemiologymedicineHumanscardiovascular diseases030212 general & internal medicineMyocardial infarctionRisk factorStrokeInhalation Exposurebusiness.industryPublic healthMortality ratemedicine.disease3. Good healthStrokeNeurologyLow and middle income countriesIschemic Attack TransientParticulate MatterNeurology (clinical)business030217 neurology & neurosurgery
researchProduct

Psychosocial factors burden in workers with acute cerebro- or cardiovascular events: A multidisciplinary prospective pilot study

2018

Introduction Psychosocial stress at work has been proposed as a risk factor for cerebro- and cardiovascular event (CVE) such as stroke or acute myocardial infarction (MI). However, data on psychosocial factors (PSF) profile in patients with CVE are scarce. In a multidisciplinary approach, we aimed to characterize PSF burden in patients with acute stroke or MI. Patients In a prospective pilot study, 45 patients aged  Results Among the 44 patients included, 77% had acute MI and 23% stroke. Mean age was 50 years, 77% were male, 43% were current smokers, 39% had hypertension, 41% hypercholesterolemia and 36% obesity. Education level was at 4,65 (secondary education), and most (41%) had low soci…

medicine.medical_specialty[SHS.PSY]Humanities and Social Sciences/PsychologyDisease030204 cardiovascular system & hematology[SHS.PSY] Humanities and Social Sciences/Psychology03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemQuality of lifeInternal medicinemedicinecardiovascular diseases030212 general & internal medicineMyocardial infarctionRisk factorStrokeComputingMilieux_MISCELLANEOUSDepression (differential diagnoses)business.industrymedicine.disease3. Good healthAnxiety[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptomCardiology and Cardiovascular MedicinebusinessPsychosocialArchives of Cardiovascular Diseases Supplements
researchProduct

Involvement of Autonomic Nervous System in New-Onset Atrial Fibrillation during Acute Myocardial Infarction

2020

Background: Atrial fibrillation (AF) is common after acute myocardial infarction (AMI) and associated with in-hospital and long-term mortality. However, the pathophysiology of AF in AMI is poorly understood. Heart rate variability (HRV), measured by Holter-ECG, reflects cardiovascular response to the autonomic nervous system and altered (reduced or enhanced) HRV may have a major role in the onset of AF in AMI patients. Objective: We investigated the relationship between autonomic dysregulation and new-onset AF during AMI. Methods: As part of the RICO survey, all consecutive patients hospitalized for AMI at Dijon (France) university hospital between June 2001 and November 2014 were analyzed …

medicine.medical_specialtyacute myocardial infarctionlcsh:Medicine030204 cardiovascular system & hematologyArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineAutonomic dysregulationHeart rate variabilityatrial fibrillationMyocardial infarctioncardiovascular diseasesEjection fractionbusiness.industryautonomic nervous systemlcsh:Rheart rate variabilityAtrial fibrillationGeneral Medicinemedicine.diseaseNew onset atrial fibrillationPathophysiologyAutonomic nervous systemCardiologybusiness030217 neurology & neurosurgeryJournal of Clinical Medicine
researchProduct